Clover Health has appointed former U.S. Senator Robert Torricelli and Dr. Brian J. Miller to its Board of Directors, filling two previously disclosed vacancies. Senator Torricelli will serve on the Audit Committee, while Dr. Miller joins the Clinical Committee, bringing the total board count to nine directors. The appointments aim to strengthen the company's expertise in federal policy, clinical medicine, and Medicare Advantage regulation.
Clover Health appointed former U.S. Senator Robert Torricelli and Dr. Brian J. Miller to its Board of Directors, filling two vacancies and bringing the board to nine members. Senator Torricelli will serve on the Audit Committee, while Dr. Miller joins the Clinical Committee, bringing expertise in federal policy, clinical medicine, and healthcare regulation. Both directors will receive pro-rated annual retainers and restricted stock units valued at $200,000 for their service through 2026.